血解决定了单细胞分化通过两个不同的途径在状细胞病血管封闭
Yunfeng Liu1, Shan Su1, Sarah Shayo1
1Laboratory of Complement Biology.
The Journal of clinical investigation
|July 25, 2023
概括
在状细胞疾病 (SCD) 中,血液溶解会影响单细胞分化. 在CSF-1和CCL-2通路之间的平衡调节单细胞命运,为SCD提供潜在的诊断和治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
背景情况:
- 状细胞疾病 (SCD) 涉及慢性血液溶解和痛苦的血管闭塞危机 (VOC).
- 单核细胞系统在SCD中至关重要,但单细胞分化机制尚不清楚.
- 血液溶解是SCD病理学的关键驱动因素,影响免疫细胞的行为.
研究的目的:
- 为了研究血解如何影响状细胞疾病中单细胞分化途径.
- 确定SCD中调节单细胞命运的特定分子机制.
- 探索基于单细胞调节的潜在诊断和治疗点.
主要方法:
- 利用SCD小鼠模型研究单细胞分化.
- 分析了CSF-1,CCL-2,Nrf2和IFN-I在单细胞调节中的作用.
- 使用阻断抗体 (抗P选择蛋白) 来研究单细胞转移.
- 在SCD患者中,血CSF-1/CCL-2比率与血液巡逻单细胞 (PMo) 水平相关.
主要成果:
- 血液溶解通过Nrf2刺激CSF-1的产生,促进古典单细胞 (CMo) 到血液巡逻单细胞 (PMo) 的分化.
- 血液溶解通过IFN-I上调CCL-2,驱动CMo转移和分化成组织巨细胞.
- 阻止CMo转移会增加循环PMo,这表明了差异化竞争.
- 在SCD患者的血CSF-1/CCL-2比率和血PMo水平之间存在正相关性.
结论:
- 在SCD中,单细胞分化受到Nrf2/CSF-1和IFN-I/CCL-2血红细胞驱动通路之间的平衡的调节.
- CSF-1/CCL-2比率是决定单细胞命运的重要因素 (组织与血液巡逻).
- 针对这些途径,特别是CSF-1/CCL-2比率,为SCD诊断和治疗提供了潜力.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Multiple Allele Traits
34.3K
The Concept of Multiple Allelism
34.3K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Extrinsic and Intrinsic Pathways of Hemostasis
8.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.3K
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K


